“In pre-clinical trials for development of MBL-specific inhibitors, Sub-inhibitory concentrations of citric acid , malic acid, ascorbic acid and ciprofloxacin in combination with imipenem or meropenem exerted synergistic activities against metallo-carbapenemases.”